François Lespérance

14.2k total citations · 3 hit papers
80 papers, 10.1k citations indexed

About

François Lespérance is a scholar working on Cardiology and Cardiovascular Medicine, Social Psychology and General Health Professions. According to data from OpenAlex, François Lespérance has authored 80 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Cardiology and Cardiovascular Medicine, 12 papers in Social Psychology and 12 papers in General Health Professions. Recurrent topics in François Lespérance's work include Cardiac Health and Mental Health (52 papers), Mental Health Treatment and Access (12 papers) and Heart Failure Treatment and Management (11 papers). François Lespérance is often cited by papers focused on Cardiac Health and Mental Health (52 papers), Mental Health Treatment and Access (12 papers) and Heart Failure Treatment and Management (11 papers). François Lespérance collaborates with scholars based in Canada, United States and Norway. François Lespérance's co-authors include Nancy Frasure‐Smith, Mario Talajic, Martial G. Bourassa, Martin Juneau, Pierre Théroux, Peter Kaufmann, C. Barr Taylor, David S. Sheps, Erika Sivarajan Froelicher and James A. Blumenthal and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

François Lespérance

80 papers receiving 9.5k citations

Hit Papers

Depression and 18-Month Prognosis After Myocardial Infarc... 1995 2026 2005 2015 1995 2008 2002 400 800 1.2k

Peers

François Lespérance
Matthew M. Burg United States
Jeff C. Huffman United States
Robert M. Carney United States
Adriaan Honig Netherlands
Alexander H. Glassman United States
Alan L. Hinderliter United States
Lana L. Watkins United States
Patrick J. Lustman United States
François Lespérance
Citations per year, relative to François Lespérance François Lespérance (= 1×) peers Nancy Frasure‐Smith

Countries citing papers authored by François Lespérance

Since Specialization
Citations

This map shows the geographic impact of François Lespérance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Lespérance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Lespérance more than expected).

Fields of papers citing papers by François Lespérance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Lespérance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Lespérance. The network helps show where François Lespérance may publish in the future.

Co-authorship network of co-authors of François Lespérance

This figure shows the co-authorship network connecting the top 25 collaborators of François Lespérance. A scholar is included among the top collaborators of François Lespérance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Lespérance. François Lespérance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grande, Claudio Del, Alina Dyachenko, Janusz Kaczorowski, et al.. (2021). Preferences for research design and treatment of comorbid depression among patients with an opioid use disorder: A cross-sectional discrete choice experiment. Drug and Alcohol Dependence. 226. 108857–108857. 6 indexed citations
2.
Furukawa, Toshi A., Mirjam Reijnders, Sanae Kishimoto, et al.. (2019). Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking. Epidemiology and Psychiatric Sciences. 29. e24–e24. 57 indexed citations
3.
Brissette, Suzanne, François Lespérance, Paul Lespérance, et al.. (2018). A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder. International Clinical Psychopharmacology. 33(5). 268–273. 6 indexed citations
4.
Houle, Janie, et al.. (2012). Treatment preferences in patients with first episode depression. Journal of Affective Disorders. 147(1-3). 94–100. 64 indexed citations
5.
Roy, Denis, Nancy Frasure‐Smith, Mario Talajic, et al.. (2012). Quality of Life and Functional Capacity in Patients With Atrial Fibrillation and Congestive Heart Failure. Journal of the American College of Cardiology. 61(4). 455–460. 76 indexed citations
6.
Guertin, Jason R., Aihua Liu, Michał Abrahamowicz, et al.. (2011). Analysis of Willingness to Pay for Implantable Cardioverter–Defibrillator Therapy. The American Journal of Cardiology. 107(3). 423–427. 7 indexed citations
7.
Groleau, Danielle, Rob Whitley, François Lespérance, & Laurence J. Kirmayer. (2010). Spiritual reconfigurations of self after a myocardial infarction: Influence of culture and place. Health & Place. 16(5). 853–860. 31 indexed citations
9.
McCaffery, Jeanne M., Qing Duan, Nancy Frasure‐Smith, et al.. (2008). Genetic predictors of depressive symptoms in cardiac patients. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(3). 381–388. 42 indexed citations
10.
Frasure‐Smith, Nancy & François Lespérance. (2008). Depression and Anxiety as Predictors of 2-Year Cardiac Events in Patients With Stable Coronary Artery Disease. Archives of General Psychiatry. 65(1). 62–62. 431 indexed citations
11.
Lespérance, François, et al.. (2007). Depression and heart disease.. Cleveland Clinic Journal of Medicine. 74(Suppl_1). S63–S63. 22 indexed citations
12.
Atar, Dan, Alex I. Malinin, Alex Pokov, et al.. (2007). Antiplatelet Properties of Escitalopram in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro Study. Neuropsychopharmacology. 32(11). 2369–2374. 19 indexed citations
13.
McCaffery, Jeanne M., Nancy Frasure‐Smith, Marie‐Pierre Dubé, et al.. (2006). Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin. Psychosomatic Medicine. 68(2). 187–200. 142 indexed citations
14.
Frasure‐Smith, Nancy & François Lespérance. (2006). Recent Evidence Linking Coronary Heart Disease and Depression. The Canadian Journal of Psychiatry. 51(12). 730–737. 162 indexed citations
15.
Frasure‐Smith, Nancy, Diana Koszycki, John Swenson, et al.. (2006). Design and Rationale for a Randomized, Controlled Trial of Interpersonal Psychotherapy and Citalopram for Depression in Coronary Artery Disease (CREATE). Psychosomatic Medicine. 68(1). 87–93. 21 indexed citations
16.
Rieckmann, Nina, William Gerin, Ian M. Kronish, et al.. (2006). Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes. Journal of the American College of Cardiology. 48(11). 2218–2222. 129 indexed citations
17.
Lespérance, François, et al.. (2004). Primary nocturnal enuresis: omega-3 fatty acids may be of therapeutic value. Medical Hypotheses. 64(6). 1188–1191. 6 indexed citations
18.
Lespérance, François, Nancy Frasure‐Smith, Marc-André Laliberté, et al.. (2003). An Open-Label Study of Nefazodone Treatment of Major Depression in Patients with Congestive Heart Failure. The Canadian Journal of Psychiatry. 48(10). 695–701. 33 indexed citations
19.
Frasure‐Smith, Nancy & François Lespérance. (2003). Depression and Other Psychological Risks Following Myocardial Infarction. Archives of General Psychiatry. 60(6). 627–627. 248 indexed citations
20.
Lespérance, François & Nancy Frasure‐Smith. (2000). Depression in patients with cardiac disease. Journal of Psychosomatic Research. 48(4-5). 379–391. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026